SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-054234
Filing Date
2021-11-04
Accepted
2021-11-04 07:16:01
Documents
73
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fulc-10q_20210930.htm   iXBRL 10-Q 3450966
2 EX-10.1 fulc-ex101_13.htm EX-10.1 77870
3 EX-31.1 fulc-ex311_9.htm EX-31.1 11866
4 EX-31.2 fulc-ex312_10.htm EX-31.2 12708
5 EX-32.1 fulc-ex321_6.htm EX-32.1 6265
6 EX-32.2 fulc-ex322_7.htm EX-32.2 6217
7 GRAPHIC gnmwj5glr14o000002.jpg GRAPHIC 30264
8 GRAPHIC gnmwj5glr14o000001.jpg GRAPHIC 29619
  Complete submission text file 0001564590-21-054234.txt   9730145

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA fulc-20210930.xsd EX-101.SCH 53248
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fulc-20210930_cal.xml EX-101.CAL 50282
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fulc-20210930_def.xml EX-101.DEF 191665
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE fulc-20210930_lab.xml EX-101.LAB 392053
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fulc-20210930_pre.xml EX-101.PRE 313259
14 EXTRACTED XBRL INSTANCE DOCUMENT fulc-10q_20210930_htm.xml XML 1649715
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38978 | Film No.: 211377986
SIC: 2834 Pharmaceutical Preparations